4.6 Article

Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 83, Issue 2, Pages 202-204

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2011-300733

Keywords

-

Funding

  1. Allergan Inc
  2. Allon Therapeutics
  3. Ceregene Inc
  4. Chelsea Therapeutics
  5. Diana Helis Henry Medical Research Foundation
  6. EMD Serono
  7. Huntington's Disease Society of America
  8. Huntington Study Group
  9. Impax Pharmaceuticals
  10. Ipsen Ltd
  11. Lundbeck Inc
  12. Michael J Fox Foundation for Parkinson's Research
  13. Medtronic
  14. Merz Pharmaceuticals
  15. National Institutes of Health
  16. National Parkinson's Foundation
  17. Neurogen
  18. St Jude Medical
  19. Teva Pharmaceutical Industries Ltd
  20. University of Rochester
  21. Parkinson's Study Group

Ask authors/readers for more resources

Background Convergence spasm refers to transient ocular convergence, miosis and accommodation associated with disconjugate gaze mimicking abducens palsy. While it may be a manifestation of brainstem pathology, this sign is often associated with conversion (somatisation) disorders and, if unrecognised as a sign of a psychogenic disorder, it may lead to unnecessary and occasionally invasive evaluation. Methods To better characterise this neuro-ophthalmologic sign, 36 subjects were studied, 13 with psychogenic movement disorders, 11 with organic movement disorders and 12 normal controls. Patients were recorded during a manoeuvre to elicit convergence spasm and the videotapes were rated by two blinded raters on a scale of 0=normal, 1=mild convergence spasm and 2=marked convergence spasm. Results Convergence spasm was present in 9/13 (69%) psychogenic movement disorders cases, 4/11 (36%) non-psychogenic movement disorders cases and 4/12 (33%) controls (p=0.049 when psychogenic vs non-psychogenic disorders or controls were compared). Inter-rater reliability analysis of the presence (rating 1 or 2) versus absence (rating 0) showed good agreement (27/36 or 75%; kappa 0.491, SE 0.141, p=0.002). Analysis for the presence of marked convergence spasm (rating 2) yielded agreement in 32/36 (88.9%) examinations (kappa 0.652, SE 0.154, p<0.001) with a specificity of 87% (sensitivity 15%). Conclusion Convergence spasm may provide benefit in the clinical examination of psychogenic movement disorders patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available